Skip to content

Embecta Corp. EMBC Change in AR

Change in AR at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-$22.68M-309%
Mannkind logo
MannkindMNKD
-$10.29M-160%
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
-$1.37M+53.4%
ICU Medical logo
ICU MedicalICUI
$24.15M+208%
Abbott logo
AbbottABT
$42M-84.0%
Insulet logo
InsuletPODD

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Embecta Corp.’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s change in AR?
Embecta Corp. (EMBC) reported change in AR of $12M in Q4 2025.
How has Embecta Corp.'s change in AR changed year-over-year?
Embecta Corp.'s change in AR increased by 306.9% year-over-year, from -$5.8M to $12M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.